SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-163458
Filing Date
2014-04-28
Accepted
2014-04-28 17:20:18
Documents
3
Period of Report
2014-06-18
Effectiveness Date
2014-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d717509ddef14a.htm DEF 14A 310481
2 GRAPHIC g717509pc_pg001.jpg GRAPHIC 225375
3 GRAPHIC g717509pc_pg002.jpg GRAPHIC 121332
  Complete submission text file 0001193125-14-163458.txt   789493
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35993 | Film No.: 14790485
SIC: 2834 Pharmaceutical Preparations